Erste Asset Management GmbH Acquires 40,000 Shares of Masimo Corporation $MASI

Erste Asset Management GmbH raised its position in shares of Masimo Corporation (NASDAQ:MASI) by 25.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 200,000 shares of the medical equipment provider’s stock after buying an additional 40,000 shares during the period. Erste Asset Management GmbH owned about 0.37% of Masimo worth $26,012,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Global Retirement Partners LLC purchased a new stake in Masimo during the 4th quarter valued at $27,000. Los Angeles Capital Management LLC purchased a new stake in Masimo during the 4th quarter valued at $31,000. Rothschild Investment LLC boosted its position in Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares during the period. Torren Management LLC purchased a new stake in Masimo during the 4th quarter valued at $35,000. Finally, Smartleaf Asset Management LLC boosted its position in Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 136 shares during the period. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

NASDAQ:MASI opened at $178.82 on Monday. The company has a 50-day moving average price of $178.45 and a 200-day moving average price of $159.41. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.00. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The stock has a market cap of $9.36 billion, a price-to-earnings ratio of -16.97, a P/E/G ratio of 1.81 and a beta of 1.11.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on MASI shares. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a research report on Tuesday, February 17th. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 price target on shares of Masimo in a research report on Tuesday, February 17th. Finally, Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Nine research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.